The effects of environmental neurotoxicants on the dopaminergic system: A possible role in drug addiction.
暂无分享,去创建一个
[1] G. Hanson,et al. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment. , 2007, Addiction.
[2] L. Rushton,et al. Pesticides and Parkinson’s Disease—Is There a Link? , 2005, Environmental health perspectives.
[3] M. Aschner,et al. The effects of manganese on glutamate, dopamine and γ-aminobutyric acid regulation , 2006, Neurochemistry International.
[4] G. Fiskum,et al. Methoxychlor inhibits brain mitochondrial respiration and increases hydrogen peroxide production and CREB phosphorylation. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[5] K. McDaniel,et al. Dopamine transporter binding in the rat striatum is increased by gestational, perinatal, and adolescent exposure to heptachlor. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[6] Y. Funae,et al. Prenatal and neonatal exposure to bisphenol-a enhances the central dopamine d1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state , 2003, Neuroscience.
[7] R. Hruska,et al. Estrogen treatment increases the density of D1 dopamine receptors in the rat striatum , 1988, Brain Research.
[8] N. Volkow,et al. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. , 2007, Addiction.
[9] A. Levey,et al. Heptachlor alters expression and function of dopamine transporters. , 1999, Neurotoxicology.
[10] E. J. Nestler,et al. Molecular neurobiology of drug addiction. , 2004, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[11] G. Miller,et al. Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] Todd B. Sherer,et al. Mechanism of Toxicity in Rotenone Models of Parkinson's Disease , 2003, The Journal of Neuroscience.
[13] M. Narita,et al. Prenatal and neonatal exposure to bisphenol-A affects the morphine-induced rewarding effect and hyperlocomotion in mice , 2004, Neuroscience Letters.
[14] A. Bortolozzi,et al. Effects of 2,4-dichlorophenoxyacetic acid exposure on dopamine D2-like receptors in rat brain. , 2004, Neurotoxicology and teratology.
[15] P. Eriksson,et al. Neonatal exposure to paraquat or MPTP induces permanent changes in striatum dopamine and behavior in adult mice. , 1993, Toxicology and applied pharmacology.
[16] S. Casteel,et al. Dietary cadmium exposure attenuates d-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity , 2005, Pharmacology Biochemistry and Behavior.
[17] C. Cavada,et al. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats , 2007, Experimental Neurology.
[18] E. Richfield,et al. Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson’s disease? , 2000, Brain Research.
[19] D. Mash,et al. Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. , 1997, Brain research. Molecular brain research.
[20] R. Kostrzewa,et al. Maternal Lead Exposure Produces Long-Term Enhancement of Dopaminergic Reactivity in Rat Offspring , 2007, Neurochemical Research.
[21] P. Palanza,et al. d-Amphetamine-related reinforcing effects are reduced in mice exposed prenatally to estrogenic endocrine disruptors , 2005, Brain Research Bulletin.
[22] G. Bratton,et al. The effects of perinatal exposure to lead on the discriminative stimulus properties of cocaine and related drugs in rats , 2001, Psychopharmacology.
[23] A. Esquifino,et al. Cadmium effects on dopamine turnover and plasma levels of prolactin, GH and ACTH , 2001, Journal of Physiology and Biochemistry.
[24] A. Krygowska-Wajs,et al. Influence of paraquat on dopaminergic transporter in the rat brain. , 2005, Pharmacological reports : PR.
[25] N. Volkow,et al. Drug addiction: the neurobiology of disrupted self-control. , 2006, Trends in molecular medicine.
[26] B. Soria,et al. Low doses of the endocrine disruptor Bisphenol‐A and the native hormone 17β‐estradiol rapidly activate the transcription factor CREB , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] A. H. V. Schapira,et al. MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.
[28] D. Mash,et al. Immunochemical Analysis of Vesicular Monoamine Transporter (VMAT2) Protein in Parkinson's Disease , 1999, Experimental Neurology.
[29] C. Roegge,et al. Motor function following developmental exposure to PCBS and/or MEHG. , 2006, Neurotoxicology and teratology.
[30] G. Bratton,et al. Exposure to cadmium during gestation and lactation decreases cocaine self-administration in rats. , 2004, Neurotoxicology.
[31] D. Mash,et al. Dopamine transport function is elevated in cocaine users , 2002, Journal of neurochemistry.
[32] R. Gross,et al. Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats , 2005, Neurobiology of Disease.
[33] Eric K. Richfield,et al. Overexpression of Superoxide Dismutase or Glutathione Peroxidase Protects against the Paraquat + Maneb-induced Parkinson Disease Phenotype* , 2005, Journal of Biological Chemistry.
[34] E. Richfield,et al. Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. , 2002, Neurotoxicology.
[35] M. Morita,et al. Effects of Neonatal Treatment With 6-Hydroxydopamine and Endocrine Disruptors on Motor Activity and Gene Expression in Rats , 2004, Neural plasticity.
[36] Dean F Wong,et al. Acute manganese administration alters dopamine transporter levels in the non-human primate striatum. , 2006, Neurotoxicology.
[37] E. Richfield,et al. Developmental Pesticide Models of the Parkinson Disease Phenotype , 2005, Environmental health perspectives.
[38] S. Faraone,et al. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder , 2007, Expert review of neurotherapeutics.
[39] M. Morita,et al. Bisphenol A causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity , 2004, Journal of neuroscience research.
[40] M. Carroll,et al. Estrogen Receptor β, but not α, Mediates Estrogen's Effect on Cocaine-Induced Reinstatement of Extinguished Cocaine-Seeking Behavior in Ovariectomized Female Rats , 2007, Neuropsychopharmacology.
[41] F. Aboitiz,et al. Behavioral effects of manganese injected in the rat substantia nigra are potentiated by dicumarol, a DT-diaphorase inhibitor , 2004, Pharmacology Biochemistry and Behavior.
[42] M. Kitazawa,et al. Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cδ in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration , 2003, Neuroscience.
[43] A. Levey,et al. Dopamine transporters and neuronal injury. , 1999, Trends in pharmacological sciences.
[44] G. Bratton,et al. Developmental Lead Exposure Alters the Stimulatory Properties of Cocaine at PND 30 and PND 90 in the Rat , 2000, Neuropsychopharmacology.
[45] A. Levey,et al. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users , 1996, Nature Medicine.
[46] G. Miller,et al. Acute exposure to aroclor 1016 or 1260 differentially affects dopamine transporter and vesicular monoamine transporter 2 levels. , 2004, Toxicology letters.
[47] F. Fonnum,et al. The effect of polychlorinated biphenyls on the high affinity uptake of the neurotransmitters, dopamine, serotonin, glutamate and GABA, into rat brain synaptosomes. , 2001, Toxicology.
[48] E. Richfield,et al. The Nigrostriatal Dopaminergic System as a Preferential Target of Repeated Exposures to Combined Paraquat and Maneb: Implications for Parkinson's Disease , 2000, The Journal of Neuroscience.
[49] T. Guilarte,et al. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates , 2006, Experimental Neurology.
[50] Michael Aschner,et al. Manganese-induced cytotoxicity in dopamine-producing cells. , 2004, Neurotoxicology.
[51] K. Matsubara,et al. Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats , 2003, Brain Research.
[52] P. Cooney,et al. Brain manganese accumulation is inversely related to gamma-amino butyric acid uptake in male and female rats. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[53] A. Bortolozzi,et al. Behavioral alterations induced in rats by a pre- and postnatal exposure to 2,4-dichlorophenoxyacetic acid. , 1999, Neurotoxicology and teratology.
[54] D. Cory-Slechta,et al. Low-level lead exposure selectively enhances dopamine overflow in nucleus accumbens: an in vivo electrochemistry time course assessment. , 1998, Toxicology and applied pharmacology.
[55] H. Rommelspacher,et al. Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: Implications for Parkinson’s disease , 2006, Neuroscience.
[56] C. Devi,et al. Developmental lead exposure alters mitochondrial monoamine oxidase and synaptosomal catecholamine levels in rat brain , 2005, International Journal of Developmental Neuroscience.
[57] M. Narita,et al. Prenatal and neonatal exposure to low-dose of bisphenol-A enhance the morphine-induced hyperlocomotion and rewarding effect , 2006, Neuroscience Letters.
[58] W. Shain,et al. Lightly chlorinated ortho-substituted PCB congeners decrease dopamine in nonhuman primate brain and in tissue culture. , 1990, Toxicology and applied pharmacology.
[59] D. Cory-Slechta. Postnatal lead exposure and MK-801 sensitivity. , 1997, Neurotoxicology.
[60] J. Yonemoto,et al. Mesencephalic neurodegeneration in the orally administered bisphenol A-caused hyperactive rats. , 2007, Toxicology letters.
[61] James Robert Brašić,et al. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users , 2008, Synapse.
[62] G. Bratton,et al. The effects of developmental cadmium exposure on morphine sensitization and challenge with selective D1 and D2 antagonists , 2002, Pharmacology Biochemistry and Behavior.
[63] G. Miller. Paraquat: the red herring of Parkinson's disease research. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[64] D. Cory-Slechta,et al. New and Evolving Concepts in the Neurotoxicology of Lead , 2007 .
[65] P. Fumagalli,et al. Vulnerability of mitochondrial complex I in PC12 cells exposed to manganese. , 1995, European journal of pharmacology.
[66] Dennis K. Miller,et al. The effects of cadmium contamination on the discriminative stimulus properties of cocaine and related drugs. , 1999, Experimental and clinical psychopharmacology.
[67] B. Stanley,et al. Postnatal manganese exposure attenuates cocaine-induced locomotor activity and reduces dopamine transporters in adult male rats. , 2006, Neurotoxicology and teratology.
[68] F. Fonnum,et al. Effect of polychlorinated biphenyls on the uptake of dopamine into rat brain synaptic vesicles: a structure-activity study. , 2001, Toxicology and applied pharmacology.
[69] Diana Brahams,et al. Medicine and the Law , 1983, The Lancet.
[70] H. Tilson,et al. Effects of polychlorinated biphenyls (PCBs) on brain tyrosine hydroxylase activity and dopamine synthesis in rats. , 1997, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[71] G. Miller,et al. Perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum. , 2005, Neurotoxicology.
[72] T. Yen,et al. Dopamine transporter binding in chronic manganese intoxication , 2003, Journal of Neurology.
[73] M. Narita,et al. Functional changes in dopamine D3 receptors by prenatal and neonatal exposure to an endocrine disruptor bisphenol‐A in mice , 2004, Addiction biology.
[74] Y. Funae,et al. Non‐genomic modulation of dopamine release by bisphenol‐A in PC12 cells , 2003, Journal of neurochemistry.
[75] E. Love,et al. Parkinson's Disease and Exposure to Rural Environmental Factors: A Population Based Case-Control Study , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[76] P. Lein,et al. Noncholinesterase mechanisms of chlorpyrifos neurotoxicity: altered phosphorylation of Ca2+/cAMP response element binding protein in cultured neurons. , 2002, Toxicology and applied pharmacology.
[77] E. Unterwald,et al. D1 dopamine receptor: A putative neurochemical and behavioral link to cocaine action , 2002, Journal of cellular physiology.
[78] J. Silverman,et al. Evidence for the involvement of ERβ and RGS9-2 in 17-β estradiol enhancement of amphetamine-induced place preference behavior , 2007, Hormones and Behavior.
[79] C. D. De Rosa,et al. Effects of polychlorinated biphenyls on the nervous system , 2000, Toxicology and industrial health.
[80] Abby A. Li,et al. Evaluation of Epidemiologic and Animal Data Associating Pesticides With Parkinson’s Disease , 2005, Journal of occupational and environmental medicine.
[81] C. Davie. A review of Parkinson's disease. , 2008, British medical bulletin.
[82] P. Sokoloff,et al. The dopamine D3 receptor and drug dependence: Effects on reward or beyond? , 2005, Neuropharmacology.
[83] M. Suda,et al. Effects of perinatal exposure to bisphenol A on brain neurotransmitters in female rat offspring. , 2006, Industrial health.
[84] T. Guilarte,et al. Manganese: recent advances in understanding its transport and neurotoxicity. , 2007, Toxicology and applied pharmacology.
[85] E. Sabban,et al. Transcriptional regulation of tyrosine hydroxylase by estrogen: opposite effects with estrogen receptors α and β and interactions with cyclic AMP , 2005 .
[86] G. Bratton,et al. Early developmental lead exposure increases sensitivity to cocaine in a self-administration paradigm , 2004, Pharmacology Biochemistry and Behavior.
[87] A. Kurunczi,et al. Behavioral effects of subchronic inorganic manganese exposure in rats. , 2007, American journal of industrial medicine.
[88] K. Cunningham,et al. Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats. , 2002, Brain research. Molecular brain research.
[89] S. Yajima,et al. Regulation of striatal dopamine receptors by estrogen , 1999, Synapse.
[90] L. Costa,et al. Neurotoxicity of pesticides: a brief review. , 2008, Frontiers in bioscience : a journal and virtual library.
[91] K A Frey,et al. Striatal dopaminergic abnormalities in human cocaine users. , 1999, The American journal of psychiatry.
[92] Gary W Miller,et al. Paraquat neurotoxicity is distinct from that of MPTP and rotenone. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[93] D. Cory-Slechta,et al. Low level lead exposure increases sensitivity to the stimulus properties of dopamine D1 and D2 agonists , 1991, Brain Research.
[94] Vellareddy Anantharam,et al. Dieldrin-induced neurotoxicity: relevance to Parkinson's disease pathogenesis. , 2005, Neurotoxicology.
[95] M. Aschner,et al. Manganese exposure and induced oxidative stress in the rat brain. , 2004, The Science of the total environment.
[96] J. Nation,et al. Developmental exposure to cadmium alters responsiveness to cocaine in the rat. , 2003, Drug and alcohol dependence.
[97] G. Hanson,et al. Role of monoamine transporters in mediating psychostimulant effects , 2005, The AAPS Journal.
[98] Myron Genel,et al. Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents , 1998 .
[99] F. Dick,et al. Parkinson's disease and pesticide exposures. , 2006, British medical bulletin.